Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.

The role of BRCA status on the prognosis of patients with epithelial ovarian cancer: a systematic review of the literature with a meta-analysis.

Sun C, Li N, Ding D, Weng D, Meng L, Chen G, Ma D.

PLoS One. 2014 May 1;9(5):e95285. doi: 10.1371/journal.pone.0095285. eCollection 2014.

PMID:
24788697
[PubMed - in process]
Free PMC Article
2.

BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study.

Lesnock JL, Darcy KM, Tian C, Deloia JA, Thrall MM, Zahn C, Armstrong DK, Birrer MJ, Krivak TC.

Br J Cancer. 2013 Apr 2;108(6):1231-7. doi: 10.1038/bjc.2013.70. Epub 2013 Mar 5.

PMID:
23462720
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2.

McLaughlin JR, Rosen B, Moody J, Pal T, Fan I, Shaw PA, Risch HA, Sellers TA, Sun P, Narod SA.

J Natl Cancer Inst. 2013 Jan 16;105(2):141-8. doi: 10.1093/jnci/djs494. Epub 2012 Dec 20.

PMID:
23257159
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Differing clinical impact of BRCA1 and BRCA2 mutations in serous ovarian cancer.

Liu G, Yang D, Sun Y, Shmulevich I, Xue F, Sood AK, Zhang W.

Pharmacogenomics. 2012 Oct;13(13):1523-35. doi: 10.2217/pgs.12.137. Review.

PMID:
23057551
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

BRCAness: finding the Achilles heel in ovarian cancer.

Rigakos G, Razis E.

Oncologist. 2012;17(7):956-62. doi: 10.1634/theoncologist.2012-0028. Epub 2012 Jun 6. Review.

PMID:
22673632
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survival.

Liu J, Cristea MC, Frankel P, Neuhausen SL, Steele L, Engelstaedter V, Matulonis U, Sand S, Tung N, Garber JE, Weitzel JN.

Cancer Genet. 2012 Jan-Feb;205(1-2):34-41. doi: 10.1016/j.cancergen.2012.01.008.

PMID:
22429596
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Unwrapping the implications of BRCA1 and BRCA2 mutations in ovarian cancer.

Hyman DM, Spriggs DR.

JAMA. 2012 Jan 25;307(4):408-10. doi: 10.1001/jama.2012.24. No abstract available.

PMID:
22274690
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.

Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ, Karlan BY, Lambrechts D, Despierre E, Barrowdale D, McGuffog L, Healey S, Easton DF, Sinilnikova O, Benítez J, García MJ, Neuhausen S, Gail MH, Hartge P, Peock S, Frost D, Evans DG, Eeles R, Godwin AK, Daly MB, Kwong A, Ma ES, Lázaro C, Blanco I, Montagna M, D'Andrea E, Nicoletto MO, Johnatty SE, Kjær SK, Jensen A, Høgdall E, Goode EL, Fridley BL, Loud JT, Greene MH, Mai PL, Chetrit A, Lubin F, Hirsh-Yechezkel G, Glendon G, Andrulis IL, Toland AE, Senter L, Gore ME, Gourley C, Michie CO, Song H, Tyrer J, Whittemore AS, McGuire V, Sieh W, Kristoffersson U, Olsson H, Borg Å, Levine DA, Steele L, Beattie MS, Chan S, Nussbaum RL, Moysich KB, Gross J, Cass I, Walsh C, Li AJ, Leuchter R, Gordon O, Garcia-Closas M, Gayther SA, Chanock SJ, Antoniou AC, Pharoah PD; EMBRACE; kConFab Investigators; Cancer Genome Atlas Research Network.

JAMA. 2012 Jan 25;307(4):382-90. doi: 10.1001/jama.2012.20.

PMID:
22274685
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Will Chinese ovarian cancer patients benefit from knowing the BRCA2 mutation status?

Liu GY, Zhang W.

Chin J Cancer. 2012 Jan;31(1):1-4. doi: 10.5732/cjc.011.10432. Epub 2011 Dec 16.

PMID:
22176776
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations.

Lacour RA, Westin SN, Meyer LA, Wingo SN, Schorge JO, Brooks R, Mutch D, Molina A, Sutphen R, Barnes M, Elder J, Teoh D, Powell CB, Choubey V, Blank S, Macdonald HR, Brady MF, Urbauer DL, Bodurka D, Gershenson DM, Lu KH.

Gynecol Oncol. 2011 May 1;121(2):358-63. doi: 10.1016/j.ygyno.2010.12.354. Epub 2011 Jan 28.

PMID:
21276604
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Fine tuning chemotherapy to match BRCA1 status.

Price M, Monteiro AN.

Biochem Pharmacol. 2010 Sep 1;80(5):647-53. doi: 10.1016/j.bcp.2010.05.015. Epub 2010 May 25. Review.

PMID:
20510205
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.

Lynch HT, Casey MJ, Snyder CL, Bewtra C, Lynch JF, Butts M, Godwin AK.

Mol Oncol. 2009 Apr;3(2):97-137. doi: 10.1016/j.molonc.2009.02.004. Epub 2009 Feb 21. Review.

PMID:
19383374
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Survival in Malignant Peripheral Nerve Sheath Tumours: A Comparison between Sporadic and Neurofibromatosis Type 1-Associated Tumours.

Porter DE, Prasad V, Foster L, Dall GF, Birch R, Grimer RJ.

Sarcoma. 2009;2009:756395. doi: 10.1155/2009/756395. Epub 2009 Apr 7.

PMID:
19360115
[PubMed]
Free PMC Article
14.

Improved survival in BRCA2 carriers with ovarian cancer.

Pal T, Permuth-Wey J, Kapoor R, Cantor A, Sutphen R.

Fam Cancer. 2007;6(1):113-9.

PMID:
17160431
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Future possibilities in the prevention of breast cancer: intervention strategies in BRCA1 and BRCA2 mutation carriers.

Eeles RA.

Breast Cancer Res. 2000;2(4):283-90. Epub 2000 May 25. Review.

PMID:
11250722
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes.

Gayther SA, Russell P, Harrington P, Antoniou AC, Easton DF, Ponder BA.

Am J Hum Genet. 1999 Oct;65(4):1021-9.

PMID:
10486320
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk